News alert: Johnson & Johnson’s one-shot COVID-19 vaccine is 66% effective in preventing moderate to severe illness, company says

Johnson & Johnson's vaccine protects against COVID-19 but not as strong as others already available, data released Friday from the company shows. Trials in the U.S. and seven other countries showed 66% effectiveness in its vaccine in preventing moderate to severe illness, the company said. It was 85% protective against the most serious symptoms. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
usatoday.com

News Alert
 
Friday, January 29
Johnson & Johnson's one-shot COVID-19 vaccine is 66% effective in preventing moderate to severe illness, company says
Johnson & Johnson's vaccine protects against COVID-19 but not as strong as others already available, data released Friday from the company shows. Trials in the U.S. and seven other countries showed 66% effectiveness in its vaccine in preventing moderate to severe illness, the company said. It was 85% protective against the most serious symptoms.
Read More
 
FOLLOW US
FB TW IG

Problem viewing email? View in browser

Unsubscribe Manage Newsletters Terms of Service Privacy Policy/Your California Privacy Rights Privacy Notice Do Not Sell My Info/Cookie Policy Feedback

Comments

Popular Posts

We have Your e-Wallet ready. Claim in 3hrs

Beneficiary countersignature modification

Commissions Successfully

Reduced Payment!.

Engr Suman wants to be friends on Facebook

Your order requires immediate confirmation.

You’re four weeks away from more followers 📱

Fwd: Claim "Climate law & governance" for your profile